To facilitate biosimilar uptake, several mechanisms aimed at reducing the acquisition cost of biosim...
Read moreHTA bodies and companies within the pharmaceutical industry have been forced to react to unprecedent...
Read moreThis study aimed to assess whether the new process has resulted in changes to outcomes of STAs.
Read moreA recent study assessed whether this new process has resulted in faster patient access.
Read moreThe UK will continue to adopt decisions taken by the European Commission on the approval of new mark...
Read moreTo facilitate biosimilar uptake, several mechanisms encouraging biosimilar uptake have been implemen...
Read moreA survey of employees within pricing and market access n pharma and biotech companies.
Read moreICER’s Health Technology Assessments review process is an assessment undertaken by one of three ap...
Read moreGVD is a core document, which may be considered the “heart” of the pharmaceutical product’s pa...
Read moreA multidisciplinary process that uses explicit methods to determine the value of a health technology...
Read more